日本批准Veltassa用于成人高血糖治疗,为管理提供了新的选择。 Japan approves Veltassa® for adult hyperkalemia treatment, offering a new option for management.

在日本,Veltassa(patiromer)已经获得核准,用于治疗患有高血糖的成年人,其特点是血液中的钾含量较高。 Veltassa® (patiromer) has received approval in Japan for treating adults with hyperkalemia, a condition characterized by elevated potassium levels in the blood. 这一批准标志着在管理这一状况方面取得重大进展,为受影响的个人提供了新的治疗选择。 This approval marks a significant advancement in the management of this condition, providing a new treatment option for affected individuals.